1. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer
- Author
-
Susanna, Stinson, Mark R, Lackner, Alex T, Adai, Nancy, Yu, Hyo-Jin, Kim, Carol, O'Brien, Jill, Spoerke, Suchit, Jhunjhunwala, Zachary, Boyd, Thomas, Januario, Robert J, Newman, Peng, Yue, Richard, Bourgon, Zora, Modrusan, Howard M, Stern, Søren, Warming, Frederic J, de Sauvage, Lukas, Amler, Ru-Fang, Yeh, and David, Dornan
- Subjects
Homeodomain Proteins ,Epithelial-Mesenchymal Transition ,Breast Neoplasms ,MAP Kinase Kinase Kinases ,Neoplasm Proteins ,DNA-Binding Proteins ,Gene Expression Regulation, Neoplastic ,Repressor Proteins ,MicroRNAs ,Cell Movement ,Humans ,Female ,Neoplasm Invasiveness ,RNA, Neoplasm ,3' Untranslated Regions ,Proto-Oncogene Proteins c-fos ,Transcription Factors ,Zinc Finger E-box Binding Homeobox 2 - Abstract
Compared with the luminal subtype, the basal-like subtype of breast cancer has an aggressive clinical behavior, but the reasons for this difference between the two subtypes are poorly understood. We identified microRNAs (miRNAs) miR-221 and miR-222 (miR-221/222) as basal-like subtype-specific miRNAs that decrease expression of epithelial-specific genes and increase expression of mesenchymal-specific genes. In addition, expression of these miRNAs increased cell migration and invasion, which collectively are characteristics of the epithelial-to-mesenchymal transition (EMT). The basal-like transcription factor FOSL1 (also known as Fra-1) directly stimulated the transcription of miR-221/222, and the abundance of these miRNAs decreased with inhibition of MEK (mitogen-activated or extracellular signal-regulated protein kinase kinase), placing miR-221/222 downstream of the RAS pathway. The miR-221/222-mediated reduction in E-cadherin abundance depended on their targeting of the 3' untranslated region (3'UTR) of TRPS1 (trichorhinophalangeal syndrome type 1), which is a member of the GATA family of transcriptional repressors. TRPS1 inhibited EMT by directly repressing expression of ZEB2 (Zinc finger E-box-binding homeobox 2). Therefore, miR-221/222 may contribute to the aggressive clinical behavior of basal-like breast cancers.
- Published
- 2011